Evidence map›Paper›PMID 18699867›Full record

ArticleMolecular microbiology2008

Developmentally regulated sphingolipid synthesis in African trypanosomes.

Shaheen S Sutterwala, Fong-Fu Hsu, Elitza S Sevova, Kevin J Schwartz, Kai Zhang, Phillip Key, John Turk, Stephen M Beverley, James D Bangs

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The lipidome ofFrontiers in cellular and infection microbiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania.International journal for parasitology. Drugs and drug resistance · 2018
    Article
  13. Article
  14. Review
  15. Lipid analysis ofCell discovery · 2018
    Article
  16. Lipidomics and anti-trypanosomatid chemotherapy.Clinical and translational medicine · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shaheen S SutterwalaDepartment of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, 1550 Linden Drive, Madison, WI 53706, USA.
Fong-Fu Hsu
Elitza S Sevova
Kevin J Schwartz
Kai Zhang
Phillip Key
John Turk
Stephen M Beverley
James D Bangs
University of Wisconsin–Madison · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
GLYCOSYLATION MUTANTS OF LEISHMANIAR01AI031078 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1992 to 2019
$11.4M
Secretory Protein Trafficking and Folding in African TrypanosomesR01AI035739 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BANGS, JAMES D. · 2000 to 2020
$6.6M
Microbial Pathogenesis &Host Responses Training ProgramT32AI055397 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2003 to 2024
$5.5M
NCRR NIH HHS P41 RR000954NCRR NIH HHS P41-RR00954NIAID NIH HHS R01 AI031078NIAID NIH HHS R01AI031078NIAID NIH HHS R01 AI035739NIAID NIH HHS R01-AI35739NIAID NIH HHS T32 AI055397NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30-DK56341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579NIGMS NIH HHS T32 GM007067Wellcome Trust
6 · The paper itself

Abstract

Sphingolipids are essential components of eukaryotic membranes, and many unicellular eukaryotes, including kinetoplastid protozoa, are thought to synthesize exclusively inositol phosphorylceramide (IPC). Here we characterize sphingolipids from Trypanosoma brucei, and a trypanosome sphingolipid synthase gene family (TbSLS1-4) that is orthologous to Leishmania IPC synthase. Procyclic trypanosomes contain IPC, but also sphingomyelin, while surprisingly bloodstream-stage parasites contain sphingomyelin and ethanolamine phosphorylceramide (EPC), but no detectable IPC. In vivo fluorescent ceramide labelling confirmed stage-specific biosynthesis of both sphingomyelin and IPC. Expression of TbSLS4 in Leishmania resulted in production of sphingomyelin and EPC suggesting that the TbSLS gene family has bi-functional synthase activity. RNAi silencing of TbSLS1-4 in bloodstream trypanosomes led to rapid growth arrest and eventual cell death. Ceramide levels were increased more than threefold by silencing suggesting a toxic downstream effect mediated by this potent intracellular messenger. Topology predictions support a revised six-transmembrane domain model for the kinetoplastid sphingolipid synthases consistent with the proposed mammalian sphingomyelin synthase structure. This work reveals novel diversity and regulation in sphingolipid metabolism in this important group of human parasites.

Indexed as

AfricaAmino Acid SequenceAnimalsGene ExpressionGene SilencingGlycosphingolipidsHumansLeishmaniaLigasesModels, BiologicalModels, MolecularMolecular Sequence DataProtozoan ProteinsSequence AlignmentSphingolipidsSphingomyelinsceramide phosphoethanolamineGlycosphingolipidsinositolphosphoceramidesLigasesProtozoan ProteinsSphingolipidsSphingomyelins

Identifiers

PMID18699867
PMCPMC2629665
OpenAlexW2143937997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.